| CTRI Number |
CTRI/2026/02/104359 [Registered on: 19/02/2026] Trial Registered Prospectively |
| Last Modified On: |
17/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Scope of biochemic five phos six x compared to homeopathic medicine on growth parameters in underweight children under five years of age group |
|
Scientific Title of Study
|
SCOPE OF BIOCHEMIC COMBINATION OF FIVE PHOS 6X VIS-À-VIS INDICATED HOMOEOPATHIC MEDICINE ON ANTHROPOMETRIC MEASUREMENTS AMONG THE UNDERWEIGHT CHILDREN UNDER 5 YEARS OF AGE GROUP (GRADE I AND GRADE II IAP CLASSIFICATION OF PROTEIN ENERGY MALNUTRITION): SINGLE-BLIND, RANDOMIZED CONTROL TRIAL |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Omkar Deepak Anavkar |
| Designation |
Ph D Scholar |
| Affiliation |
Dr M L Dhawale Memorial Homoeopathic Institute |
| Address |
Room Number three hundred and four Doctor M L Dhawale Memorial Homoeopathic Institute Department of Paediatrics Palghar Boisar Road Opposite S T Workshop
Palghar MAHARASHTRA 401404 India |
| Phone |
7039499102 |
| Fax |
|
| Email |
omkaranavkar@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Chandrasekhar Goda |
| Designation |
HOD and Professor of Dept. of Paediatrics |
| Affiliation |
Dr M L Dhawale Memorial Homoeopathic Institute |
| Address |
Room Number three hundred and five Doctor M L Dhawale Memorial Homoeopathic Institute Department of Paediatrics Palghar Boisar Road Opposite S T Workshop
Palghar MAHARASHTRA 401404 India |
| Phone |
9322882918 |
| Fax |
|
| Email |
sujchan18@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bipin S Jain |
| Designation |
Principal |
| Affiliation |
Dr M L Dhawale Memorial Homoeopathic Institute |
| Address |
Room Number one hundred and thirty four Doctor M L Dhawale Memorial Homoeopathic Institute Department of Paediatrics Palghar Boisar Road Opposite S T Workshop
Palghar MAHARASHTRA 401404 India |
| Phone |
9323690095 |
| Fax |
|
| Email |
principalmldmhi@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr M L Dhawale Memorial Trust Institute Boisar Road Opp S T Workshop District Palghar Maharashtra India 401404 |
|
|
Primary Sponsor
|
| Name |
Dr. M L Dhawale Memorial Trust Hospital, Palghar |
| Address |
Doctor M L Dhawale Memorial Trust Hospital Palghar Boisar Road Opposite S T Workshop Palghar 401 104 District Palghar Maharashtra India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Omkar Anavkar |
Dr M L Dhawale Memorial Homoeopathic Institute |
Room no 304 Department of Paediatrics Palghar Boisar road opp ST workshop district Palghar Maharashtra India 401404 Palghar MAHARASHTRA |
7039499102
omkaranavkar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, MLDMHI, Palghar |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E44||Protein-calorie malnutrition of moderate and mild degree, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Five Phos 6x Group |
6X TDS ORALLY FOR 12 MONTHS |
| Comparator Agent |
Group 2- Indicated homoeopathic medicine group- |
The most indicated homoeopathic medicine will be prescribed in an appropriate potency (30, 200, or 1M) and repetition (once per week, three times per week, daily, twice daily, three times daily, or four times daily) administered orally based on the susceptibility of the patient for a total duration of twelve months. |
|
|
Inclusion Criteria
|
| Age From |
6.00 Month(s) |
| Age To |
5.00 Year(s) |
| Gender |
Both |
| Details |
1 Children diagnosed with Grade one and Grade two malnutrition as per IAP guidelines.
2 Children within the age group of six months to five years.
3 Participants of both genders including boys and girls.
4 Children with recurrent respiratory illnesses such as rhinitis, laryngitis, tonsillitis, and pharyngitis, gastric complaints such as worm infection, constipation, and diarrhoea, skin complaints such as scabies and dermatitis.
5 Cases in which parents or legal guardians provide written informed consent and assent for their children. |
|
| ExclusionCriteria |
| Details |
Children with a known case of any major illness like any congenital anomalies such as cleft lip, cleft palate, or congenital heart disease, tuberculosis or childhood cancer, cystic fibrosis or cerebral palsy. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate and compare the efficacy of the biochemic combination of five phos 6x versus indicated homoeopathic medicines on improving anthropometric measurements in underweight children with PEM under 5 years of age group (grade I and grade II IAP classification of PEM) in 12 months. |
Time Points: 0 (Baseline), 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52 weeks. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To know the commonly used homoeopathic medicines in the management of underweight children under five years of age |
At the completion of twelve months of treatment |
| To know the commonly used posology in the management of underweight children under five years of age |
At the completion of twelve months of treatment |
|
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
04/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="4" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a single blind randomized control trial designed with a primary objective to evaluate and compare the efficacy of a biochemic intervention against indicated homoeopathic medicine in improving the anthropometric measurements of children classified as grade one and grade two protein energy malnutrition as per Indian Academy of Pediatrics classification.
The need for this study stems from the significant global and national burden of undernutrition, particularly in India, where a high percentage of children under five are underweight. Malnutrition is a major public health challenge linked to increased susceptibility to infections, delayed cognitive development, and higher mortality rates. By exploring a homoeopathic approach, this study seeks to provide a potentially effective and safe alternative or complementary treatment to conventional methods.
The methodology involves recruiting children based on defined inclusion and exclusion criteria. The randomization sequence will be generated using a computer generated random number table to ensure unbiased allocation into two study groups. Allocation will be concealed from the investigator and participants at the point of enrollment using sequentially numbered opaque sealed envelopes, which will be opened only after the participant is officially enrolled. Participants will receive either biochemic combination of five phos six x or an indicated homoeopathic medicine. This is a single blind study where the participants remain unaware of their specific group assignment, while the investigator remains aware to facilitate the administration of individualized medicines.
The primary outcome will be measured through changes in anthropometric parameters including weight, height, mid upper arm circumference, and head circumference at monthly intervals for twelve months to evaluate improvement in nutritional status. The findings from this research are expected to contribute valuable data to the field of homoeopathy and offer a potential therapeutic option for addressing pediatric undernutrition. |